Keros Therapeutics, Inc. (KROS)
11.30
-0.41
(-3.50%)
USD |
NASDAQ |
Mar 06, 16:00
11.30
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics SG&A Expense (TTM) : 35.11M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| MannKind Corp. | 229.86M |
| Sarepta Therapeutics, Inc. | 491.72M |
| PTC Therapeutics, Inc. | 347.14M |
| Insmed, Inc. | 701.17M |